We are live on ! Find out more
AHC

Anderson Hoagland & Co Portfolio holdings

AUM $1.28B
1-Year Est. Return 29.05%
This Fund
S&P 500
This Quarter Est. Return
+11.42%
1 Year Est. Return
+29.05%
3 Year Est. Return
+95.06%
5 Year Est. Return
+101.06%
10 Year Est. Return
+1,125.4%
AUM
$177M
AUM Growth
+$12.1M
Cap. Flow
-$2.91M
Cap. Flow %
-1.65%
Top 10 Hldgs %
44.53%
Holding
89
New
5
Increased
15
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.82M
2
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$877K
3
INTC icon
Intel
INTC
+$825K
4
CPAY icon
Corpay
CPAY
+$765K
5
SNA icon
Snap-on
SNA
+$754K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.8M
2
ILMN icon
Illumina
ILMN
+$1.17M
3
DEO icon
Diageo
DEO
+$1.07M
4
BAC icon
Bank of America
BAC
+$973K
5
HUBB icon
Hubbell
HUBB
+$785K

Sector Composition

Rank Sector Weight
1 Technology 21.55%
2 Financials 20.79%
3 Consumer Discretionary 12.69%
4 Communication Services 10.48%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHL
76
DELISTED
China Mobile Limited
CHL
$465K 0.26%
12,115
NAB
77
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$436K 0.25%
49,750
FTV icon
78
Fortive
FTV
$18.6B
$420K 0.24%
9,221
BMY.RT
79
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$53K 0.03%
+18,610
New +$48.4K
BAP icon
80
Credicorp
BAP
$30.6B
-2,990
Closed -$619K
DEO icon
81
Diageo
DEO
$53.6B
-6,230
Closed -$1.07M
HUBB icon
82
Hubbell
HUBB
$27.3B
-5,985
Closed -$785K
JWN
83
DELISTED
Nordstrom
JWN
-20,830
Closed -$603K
CELG
84
DELISTED
Celgene Corp
CELG
-18,610
Closed -$1.8M

Similar funds

Anderson Hoagland & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Anderson Hoagland & Co held 89 positions worth $177M, up 7.3% from $165M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Anderson Hoagland & Co's Q4 2019 filing shows 5 new, 15 increased, 16 reduced and 5 closed positions. Its largest new stake was Bristol-Myers Squibb: 31,695 shares worth $1.8M. The largest sale was Celgene Corp, an estimated $1.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Anderson Hoagland & Co's largest Q4 2019 buy was Bristol-Myers Squibb: 31,695 shares worth $1.8M.
  • Anderson Hoagland & Co added most to Intel in Q4 2019, an estimated $825K increase.
  • Anderson Hoagland & Co's biggest Q4 2019 reduction was Illumina, cutting an estimated $1.17M.
  • Anderson Hoagland & Co fully exited Celgene Corp in Q4 2019, selling an estimated $1.8M.
  • Anderson Hoagland & Co's ten largest holdings make up 45% of its $177M portfolio in Q4 2019.
  • Anderson Hoagland & Co opened 5 new positions and closed 5 in Q4 2019.
  • Anderson Hoagland & Co's portfolio value rose 7.3% quarter-over-quarter to $177M.

Based on Anderson Hoagland & Co's 13F filing for Q4 2019, filed 6 Jan 2020.